Dow Down 0.18% Nasdaq Down 0.33%

Rigel Pharmaceuticals, Inc. (RIGL)

-NasdaqGS
1.91 Oct 29, 4:00PM EDT
Prev Close:1.91
Open:N/A
Bid:1.70 x 100
Ask:2.35 x 100
1y Target Est:6.50
Beta:1.64
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:1.56 - 5.00
Volume:0
Avg Vol (3m):575,628
Market Cap:167.68M
P/E (ttm):N/A
EPS (ttm):-1.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
RIGL 0.00%167.68M
AMGN120.91B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):29.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.08
Quarterly EPS Est (Sep-14) :-0.27
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback